ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 35 filers reported holding ESSA PHARMA INC in Q3 2023. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $73 | – | 27 | -76.1% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 113 | -99.3% | 0.00% | – |
| Q3 2022 | $30,000 | -56.5% | 16,760 | -23.7% | 0.00% | -100.0% |
| Q2 2022 | $69,000 | +2200.0% | 21,968 | +4728.1% | 0.00% | – |
| Q1 2022 | $3,000 | -40.0% | 455 | +29.6% | 0.00% | – |
| Q4 2021 | $5,000 | -90.9% | 351 | -94.9% | 0.00% | -100.0% |
| Q3 2021 | $55,000 | – | 6,890 | +7641.6% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 89 | -55.5% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 200 | -50.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 400 | +100.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |